According to Mankind Pharma's latest financial reports the company has $0.28 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-03-31 | $0.16 B | -38.18% |
2021-03-31 | $0.27 B | 89.78% |
2020-03-31 | $0.14 B |